Oncogenic role of SOX9 expression in human malignant glioma
- 20 June 2012
- journal article
- Published by Springer Science and Business Media LLC in Medical Oncology
- Vol. 29 (5), 3484-3490
- https://doi.org/10.1007/s12032-012-0267-z
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humansThe Esophagus, 2011
- Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomasOncogene, 2010
- Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acidJCI Insight, 2009
- Analysis of SOX9 Expression in Colorectal CancerAmerican Journal of Clinical Pathology, 2008
- SOX9 expression is a general marker of basal cell carcinoma and adnexal‐related neoplasmsJournal of Cutaneous Pathology, 2008
- FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD)The Journal of Pathology, 2008
- Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarraysBritish Journal of Cancer, 2007
- Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cellsCancer Letters, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determinationProceedings of the National Academy of Sciences of the United States of America, 2002